At-home diagnostic devices using silicon photonics for chronic disease management
SiPhox Health manufactures direct-to-consumer at-home diagnostic kits built on silicon-photonics technology for protein and hormone testing. The stack spans embedded systems (FreeRTOS, Zephyr, ThreadX, STM32, ESP32, NXP), full-stack web infrastructure (Node.js, React, AWS/GCP/Azure), and AI/ML pipelines (LangChain, LlamaIndex, RAG) — indicating a hardware-software hybrid operation scaling from device firmware through cloud data ingestion to clinical result interpretation. Active projects focus simultaneously on production firmware, biomarker validation, QMS scaling, and AI-driven lab-value parsing, reflecting a company in transition from prototype to mass-market manufacturing.
SiPhox Health develops at-home diagnostic devices that miniaturize laboratory blood testing using silicon photonics and microfluidics technology. The company targets consumers managing chronic conditions, offering comprehensive biomarker panels covering longevity, fertility, and thyroid health. Operations span device manufacturing, cloud infrastructure for result delivery and patient engagement, and clinical validation. With 11–50 employees based in Burlington, MA, the team includes embedded engineers, manufacturing specialists, and healthcare professionals working to scale production quality systems while maintaining clinical accuracy of AI-extracted lab values.
Embedded systems (FreeRTOS, Zephyr, ThreadX, STM32, ESP32, NXP), full-stack web (Node.js, React, TypeScript), cloud (AWS, GCP, Azure), data/AI (Python, SQL, R, LangChain, LlamaIndex, RAG), and sales tools (HubSpot, Apollo, LinkedIn).
United States, United Kingdom, and Slovenia. Most active hiring is engineering-focused, with secondary hiring in ops, manufacturing, and quality assurance.
Other companies in the same industry, closest in size